POLYMORPH OF SODIUM NERIDRONATE AND PREPARATION PROCESS THEREOF

Mexico Patent

PATENT NO 385449
APP PUB NO MX-2020010744-A
SERIAL NO

2020010744

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a novel crystalline hemihydrate polymorph of neridronic acid sodium salt, and a novel process for the preparation thereof 5 comprising the steps of: 1) dissolving solid sodium neridronate in any crystalline form in water, at a temperature in the range from 70 to 90°C, to obtain an aqueous solution of sodium neridronate; 2) adding a solvent selected from the group consisting in ethanol, 1-propanol, and 2-propanol to the aqueous solution obtained from step (1), so that the final water:solvent volume ratio is in the range from 1:0.5 0 to 1:1, thus obtaining a suspension; 3) placing the suspension obtained from step (2) under mechanical stirring, at a temperature in the range from 60 to 95°C; 4) recovering the crystalline hemihydrate form F of sodium neridronate formed in the previous step (3). The crystalline hemihydrate form F of sodium neridronate, particularly stable, may be employed in the preparation of solid oral pharmaceutical 5 forms for use in the treatment of musculoskeletal and calcium metabolism disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABIOGEN PHARMA SPAIT56121 OSPEDALETTO (PISA)

International Classification(s)

Inventor(s)

Inventor Name Address
GIAFFREDA STEFANO LUCA 40026 IMOLA (BO)
NEGGIANI FABIO 56123 PISA
DINI LAURA 56127 PISA
ROEDER MICHAEL ZIERENBERG
ZHANG KESHENG 5600 LENZBURG
POLITI BARBARA 57128 LIVORNO
FABBRONI SERENA 40059 MEDICINA
PETROLATI ALEX 60019 SENIGALLIA
CHIARUCCI MICHEL 40055 CASTENASO

Cited Art Landscape

Load Citation